Construction of a Prefabricated Modular Building for a Thermal Disinfection and Decontamination Station for Pathogenicity Groups III–IV Effluents

The INEX engineering team has initiated a high-profile project to develop the technical design and documentation for the modernization of research and quality control laboratories at SPbNIIVS FMBA Russia. This institute is a cornerstone of Russia’s federal medical-biological defense, specializing in vaccine development and bacterial preparation manufacturing.

Following an extensive site audit and technical consultations with the institute’s experts, INEX has defined the engineering workflows for two critical sectors:

[Image: Engineering 3D model of a multi-story laboratory complex with specialized HVAC zoning]

1. Quality Control (QC) Laboratory (2nd Floor) This facility is engineered for the rigorous testing of Active Pharmaceutical Ingredients (APIs) and Finished Products (FP), including:

• Polysaccharide & Recombinant Proteins: Products derived from Escherichia coli strains.

• Conjugated Vaccines: Including PCV, MCV, and Hib.

• Enzyme Preparations: Handling strains classified under Pathogenicity Groups III-IV (e.g., Collalisin).

2. Research & Development (R&D) Laboratory (3rd Floor) A high-containment environment designed for cutting-edge biotechnological research, featuring:

• Biosafety Levels: Specialized zones for working with Pathogenic Biological Agents (PBA) of Groups II, III, and IV.

• Cell Culture & Virology: Facilities for mammalian and insect cell cultures, recombinant products, and viral vectors.

• Analytical Validation: Dedicated areas for method validation and high-precision analysis.

[Image: Cleanroom interior showing biological safety cabinets and localized exhaust systems]

This project solidifies a long-term strategic partnership between INEX and SPbNIIVS FMBA Russia, focused on advancing the infrastructure for federal vaccine security and innovative biotechnology.

Regulatory Compliance (RF)

The design phase strictly adheres to both national and international biosafety and pharmaceutical standards:

• SanPiN 3.3686-21: Governing the safety protocols for working with Pathogenic Biological Agents (Groups II-IV).

• EAEU GMP & GLP: Ensuring that both the manufacturing and laboratory environments meet international Good Manufacturing and Laboratory Practice standards.

• ISO 14644 (GOST R ISO 14644): For the classification and monitoring of air cleanliness in critical research zones.

• SP 158.13330.2014: Russian federal design standards for medical and research institutions.